scispace - formally typeset
J

Joan Figueras

Researcher at University of Barcelona

Publications -  26
Citations -  1010

Joan Figueras is an academic researcher from University of Barcelona. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 13, co-authored 26 publications receiving 945 citations. Previous affiliations of Joan Figueras include Bellvitge University Hospital.

Papers
More filters
Journal ArticleDOI

Spanish Experience in Liver Transplantation for Hilar and Peripheral Cholangiocarcinoma

TL;DR: OLT for nondisseminated irresectable cholangiocarcinoma has higher survival rates at 3 and 5 years than palliative treatments, especially with tumors in their initial stages, which means that more information is needed to help better select cholangeous liver transplantation patients for transplantation.
Journal ArticleDOI

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

TL;DR: Transcatheter arterial chemoembolization has been used as a palliative treatment for patients with unresectable hepatocellular carcinoma, but its prognostic usefulness has not previously been clarified.
Journal ArticleDOI

Analysis of the complications of the piggy-back technique in 1112 liver transplants

TL;DR: A recent decrease in the time to development of monomorphous and polymor-phous posttransplantlymphoproliferative disorder in kidney transplant patients in thenew immunosuppressive era is seen.
Journal ArticleDOI

Hilar Dissection versus the “Glissonean” Approach and Stapling of the Pedicle for Major Hepatectomies: A Prospective, Randomized Trial

TL;DR: Although en bloc stapling transection is faster, hilar dissection was associated with a shorter pedicular clamping time, less cytolysis, and the materials required were less expensive.
Journal ArticleDOI

Liver transplantation in hepatitis C. A Spanish multi-centre experience

TL;DR: HCV-cirrhosis represented the most frequent indication for OLT in Spain in 1992 and was not associated with chronic rejection, nor with a higher retransplantation rate, and patient survival was not different in HCV patients compared to a control group after a follow-up of 2–3 years.